<DOC>
	<DOCNO>NCT03011866</DOCNO>
	<brief_summary>Multilevel decompression bone graft fusion effective measure treat degenerative lumbar spinal disease . Yet , surgery commonly associate large amount perioperative blood loss high demand homologous blood transfusion . Tranexamic acid ( TXA ) prove efficient reduce gross blood loss various kind surgery . However , high quality evidence efficacy safety still lack lumbar spinal surgery . Besides , systemic use TXA carry risk thromboembolic complication deep venous thrombosis pulmonary embolism , thus optimal drug delivery route TXA remain undetermined . The aim study test non-inferiority topical TXA application intravenous use multilevel decompression bone graft fusion surgery . A prospective , randomize , double-blind , head-to-head comparison study design adopt .</brief_summary>
	<brief_title>Tranexamic Acid Reducing Gross Hemorrhage Transfusions Spine Surgeries</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>American Society Anesthesiologists ( ASA ) classification physical status III . Aged 50yrs . Patients suffer spinal stenosis intervertebral disc displacement require multilevel decompression bone graft fusion surgery . Written informed consent . ASA IIIIV . Ageâ‰¤ 50yrs . History chronic renal dysfunction ( preoperative blood creatinine &gt; 120mmol/L ) , liver dysfunction ( preoperative blood aspartate alanine aminotransferase &gt; 50 units/L ) history coronary artery disease stent placement . Abnormal preoperative coagulation profile ( preoperative prothrombin time elongation &gt; 3 , activate partial thromboplastin time elongation &gt; 10 , platelet count &lt; 100*10^9/L &gt; 400*10^9/L , INR &gt; 1.4 ) . Preexisting anemia ( male &lt; 12g/dL , female &lt; 11g/dL ) . Longterm medication aspirin and/or anticoagulant . Patients know allergic TXA . Patients religious and/or belief limit blood transfusion . Dura mater laceration and/or unexpected massive bleeding operation . Cell saver application operation .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>